Embla Medical hf. (CPH:EMBLA)

Market Cap	12.73B -15.3%
Revenue (ttm)	5.91B +8.6%
Net Income	530.09M +22.1%
EPS	1.24 +21.0%
Shares Out	427.15M
PE Ratio	24.00
Forward PE	19.72
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,486
Average Volume	56,849
Open	29.80
Previous Close	29.80
Day's Range	29.30 - 30.00
52-Week Range	25.01 - 37.90
Beta	0.46
RSI	27.53
Earnings Date	Feb 3, 2026

About Embla Medical

Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and bionic products microprocessor-controlled feet, knees, hands, fingers, and neuro orthotic joints. Its Bracing and Supports segment provides bracing and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1971
• Employees: 4,000
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: EMBLA

Financial Performance

In 2025, Embla Medical's revenue was $928.69 million, an increase of 8.63% compared to the previous year's $854.89 million. Earnings were $83.34 million, an increase of 22.05%.

Financial numbers in USD